APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza NA Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Influenza NA Inhibitor Industry Growth and Trends Forecast to 2032

2 January 202695 pages

Choose your research edition.

Industry ResearchInfluenza NA Inhibitor Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza NA Inhibitor Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Influenza NA Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza NA Inhibitor Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza NA Inhibitor Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Influenza NA Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Influenza NA Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Influenza NA Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza NA Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza NA Inhibitor include ATK Chemical, Chemwill Asia Co.,Ltd., Green Cross, Moksha8 Pharma, NeoPharm, Shionogi Co., GlaxoSmithKline, Henan DaKen Chemical and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Influenza NA Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza NA Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza NA Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza NA Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Influenza NA Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza NA Inhibitor Market by Company

ATK Chemical

Chemwill Asia Co.,Ltd.

Green Cross

Moksha8 Pharma

NeoPharm

Shionogi Co.

GlaxoSmithKline

Henan DaKen Chemical

Roche

Influenza NA Inhibitor Segment by Type

Zanamivir

Peramivir

Oseltamivir

Influenza NA Inhibitor Segment by Application

Influenza A Treatment

Influenza B Treatment

Influenza NA Inhibitor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza NA Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza NA Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza NA Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza NA Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Influenza NA Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Zanamivir Table 2. Major Company of Peramivir Table 3. Major Company of Oseltamivir Table 4. Global Influenza NA Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Influenza NA Inhibitor Sales by Type (2021-2026) & (Tons) Table 6. Global Influenza NA Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 7. Global Influenza NA Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 8. Global Influenza NA Inhibitor Sales Market Share in Value by Type (2021-2026) Table 9. Global Influenza NA Inhibitor Price by Type (2021-2026) & (US$/Kg) Table 10. Global Influenza NA Inhibitor Sales by Type (2027-2032) & (Tons) Table 11. Global Influenza NA Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 12. Global Influenza NA Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 13. Global Influenza NA Inhibitor Sales Market Share in Value by Type (2027-2032) Table 14. Global Influenza NA Inhibitor Price by Type (2027-2032) & (US$/Kg) Table 15. North America Influenza NA Inhibitor Sales by Type (2021-2026) & (Tons) Table 16. North America Influenza NA Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Influenza NA Inhibitor Sales by Type (2021-2026) & (Tons) Table 18. Europe Influenza NA Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Influenza NA Inhibitor Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Influenza NA Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Influenza NA Inhibitor Sales by Type (2021-2026) & (Tons) Table 22. Latin America Influenza NA Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Influenza NA Inhibitor Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Influenza NA Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 25. Influenza NA Inhibitor Industry Trends Table 26. Influenza NA Inhibitor Industry Drivers Table 27. Influenza NA Inhibitor Industry Opportunities and Challenges Table 28. Influenza NA Inhibitor Industry Restraints Table 29. Global Influenza NA Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Influenza NA Inhibitor Revenue Market Share by Company (2021-2026) Table 31. Global Influenza NA Inhibitor Sales by Company (2021-2026) & (Tons) Table 32. Global Influenza NA Inhibitor Sales Share by Company (2021-2026) Table 33. Global Influenza NA Inhibitor Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Influenza NA Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Influenza NA Inhibitor Major Company Production Sites and Headquarters Table 36. Global Influenza NA Inhibitor Company, Product Type & Application Table 37. Global Influenza NA Inhibitor Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Influenza NA Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Influenza NA Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Influenza NA Inhibitor Sales by Region (2021-2026) & (Tons) Table 42. Global Influenza NA Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 43. Global Influenza NA Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 44. Global Influenza NA Inhibitor Sales Market Share in Value by Region (2021-2026) Table 45. Global Influenza NA Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Influenza NA Inhibitor Sales by Region (2027-2032) & (Tons) Table 47. Global Influenza NA Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 48. Global Influenza NA Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 49. Global Influenza NA Inhibitor Sales Market Share in Value by Region (2027-2032) Table 50. Global Influenza NA Inhibitor Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Influenza NA Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Influenza NA Inhibitor Sales by Application (2021-2026) & (Tons) Table 53. Global Influenza NA Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 54. Global Influenza NA Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 55. Global Influenza NA Inhibitor Sales Market Share in Value by Application (2021-2026) Table 56. Global Influenza NA Inhibitor Price by Application (2021-2026) & (US$/Kg) Table 57. Global Influenza NA Inhibitor Sales by Application (2027-2032) & (Tons) Table 58. Global Influenza NA Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 59. Global Influenza NA Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 60. Global Influenza NA Inhibitor Sales Market Share in Value by Application (2027-2032) Table 61. Global Influenza NA Inhibitor Price by Application (2027-2032) & (US$/Kg) Table 62. North America Influenza NA Inhibitor Sales by Application (2021-2026) & (Tons) Table 63. North America Influenza NA Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Influenza NA Inhibitor Sales by Application (2021-2026) & (Tons) Table 65. Europe Influenza NA Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Influenza NA Inhibitor Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Influenza NA Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Influenza NA Inhibitor Sales by Application (2021-2026) & (Tons) Table 69. Latin America Influenza NA Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Influenza NA Inhibitor Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Influenza NA Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 72. ATK Chemical Company Information Table 73. ATK Chemical Business Overview Table 74. ATK Chemical Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. ATK Chemical Influenza NA Inhibitor Product Portfolio Table 76. ATK Chemical Recent Development Table 77. Chemwill Asia Co.,Ltd. Company Information Table 78. Chemwill Asia Co.,Ltd. Business Overview Table 79. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolio Table 81. Chemwill Asia Co.,Ltd. Recent Development Table 82. Green Cross Company Information Table 83. Green Cross Business Overview Table 84. Green Cross Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Green Cross Influenza NA Inhibitor Product Portfolio Table 86. Green Cross Recent Development Table 87. Moksha8 Pharma Company Information Table 88. Moksha8 Pharma Business Overview Table 89. Moksha8 Pharma Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Moksha8 Pharma Influenza NA Inhibitor Product Portfolio Table 91. Moksha8 Pharma Recent Development Table 92. NeoPharm Company Information Table 93. NeoPharm Business Overview Table 94. NeoPharm Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. NeoPharm Influenza NA Inhibitor Product Portfolio Table 96. NeoPharm Recent Development Table 97. Shionogi Co. Company Information Table 98. Shionogi Co. Business Overview Table 99. Shionogi Co. Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Shionogi Co. Influenza NA Inhibitor Product Portfolio Table 101. Shionogi Co. Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Influenza NA Inhibitor Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Henan DaKen Chemical Company Information Table 108. Henan DaKen Chemical Business Overview Table 109. Henan DaKen Chemical Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Henan DaKen Chemical Influenza NA Inhibitor Product Portfolio Table 111. Henan DaKen Chemical Recent Development Table 112. Roche Company Information Table 113. Roche Business Overview Table 114. Roche Influenza NA Inhibitor Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Roche Influenza NA Inhibitor Product Portfolio Table 116. Roche Recent Development Table 117. North America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 118. North America Influenza NA Inhibitor Sales by Country (2021-2026) & (Tons) Table 119. North America Influenza NA Inhibitor Sales Market Share by Country (2021-2026) Table 120. North America Influenza NA Inhibitor Sales Forecast by Country (2027-2032) & (Tons) Table 121. North America Influenza NA Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 122. North America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Influenza NA Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Influenza NA Inhibitor Market Share by Country (2021-2026) Table 125. North America Influenza NA Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Influenza NA Inhibitor Market Share Forecast by Country (2027-2032) Table 127. Europe Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 128. Europe Influenza NA Inhibitor Sales by Country (2021-2026) & (Tons) Table 129. Europe Influenza NA Inhibitor Sales Market Share by Country (2021-2026) Table 130. Europe Influenza NA Inhibitor Sales Forecast by Country (2027-2032) & (Tons) Table 131. Europe Influenza NA Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Influenza NA Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Influenza NA Inhibitor Market Share by Country (2021-2026) Table 135. Europe Influenza NA Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Influenza NA Inhibitor Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Influenza NA Inhibitor Sales by Country (2021-2026) & (Tons) Table 139. Asia-Pacific Influenza NA Inhibitor Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Influenza NA Inhibitor Sales Forecast by Country (2027-2032) & (Tons) Table 141. Asia-Pacific Influenza NA Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Influenza NA Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Influenza NA Inhibitor Market Share by Country (2021-2026) Table 145. Asia-Pacific Influenza NA Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Influenza NA Inhibitor Market Share Forecast by Country (2027-2032) Table 147. Latin America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 148. Latin America Influenza NA Inhibitor Sales by Country (2021-2026) & (Tons) Table 149. Latin America Influenza NA Inhibitor Sales Market Share by Country (2021-2026) Table 150. Latin America Influenza NA Inhibitor Sales Forecast by Country (2027-2032) & (Tons) Table 151. Latin America Influenza NA Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Influenza NA Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Influenza NA Inhibitor Market Share by Country (2021-2026) Table 155. Latin America Influenza NA Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Influenza NA Inhibitor Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Influenza NA Inhibitor Sales by Country (2021-2026) & (Tons) Table 159. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Influenza NA Inhibitor Sales Forecast by Country (2027-2032) & (Tons) Table 161. Middle East and Africa Influenza NA Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Influenza NA Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Influenza NA Inhibitor Market Share by Country (2021-2026) Table 165. Middle East and Africa Influenza NA Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Influenza NA Inhibitor Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Influenza NA Inhibitor Distributors List Table 170. Influenza NA Inhibitor Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Influenza NA Inhibitor Image Figure 2. Global Influenza NA Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza NA Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza NA Inhibitor Sales (2021-2032) & (Tons) Figure 5. Zanamivir Image Figure 6. Global Zanamivir Sales YoY Growth (2021-2032) & (Tons) Figure 7. Peramivir Image Figure 8. Global Peramivir Sales YoY Growth (2021-2032) & (Tons) Figure 9. Oseltamivir Image Figure 10. Global Oseltamivir Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Influenza NA Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Influenza NA Inhibitor Market Share by Type 2025 VS 2032 Figure 13. North America Influenza NA Inhibitor Sales Market Share in Volume by Type in 2025 Figure 14. North America Influenza NA Inhibitor Sales Market Share in Value by Type in 2025 Figure 15. Europe Influenza NA Inhibitor Sales Market Share in Volume by Type in 2025 Figure 16. Europe Influenza NA Inhibitor Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Value by Type in 2025 Figure 19. Latin America Influenza NA Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Influenza NA Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Influenza NA Inhibitor Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Influenza A Treatment Image Figure 26. Global Influenza A Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 27. Influenza B Treatment Image Figure 28. Global Influenza B Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Influenza NA Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Influenza NA Inhibitor Market Share by Application 2025 VS 2032 Figure 31. North America Influenza NA Inhibitor Sales Market Share in Volume by Application in 2025 Figure 32. North America Influenza NA Inhibitor Sales Market Share in Value by Application in 2025 Figure 33. Europe Influenza NA Inhibitor Sales Market Share in Volume by Application in 2025 Figure 34. Europe Influenza NA Inhibitor Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Value by Application in 2025 Figure 37. Latin America Influenza NA Inhibitor Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Influenza NA Inhibitor Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Value by Application in 2025 Figure 41. North America Influenza NA Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Influenza NA Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Influenza NA Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Influenza NA Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Influenza NA Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Influenza NA Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Influenza NA Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Influenza NA Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Influenza NA Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Influenza NA Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Influenza NA Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Influenza NA Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Influenza NA Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Influenza NA Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Influenza NA Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Influenza NA Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Influenza NA Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Influenza NA Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Influenza NA Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Influenza NA Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Influenza NA Inhibitor Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Influenza NA Inhibitor Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Zanamivir
  • Peramivir
  • Oseltamivir
Applications
  • Influenza A Treatment
  • Influenza B Treatment
Companies covered
  • ATK Chemical
  • Chemwill Asia Co.,Ltd.
  • Green Cross
  • Moksha8 Pharma
  • NeoPharm
  • Shionogi Co.
  • GlaxoSmithKline
  • Henan DaKen Chemical
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza NA Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Influenza NA Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Influenza NA Inhibitor Market by Type
  6. 1.3.1 Zanamivir
  7. 1.3.2 Peramivir
  8. 1.3.3 Oseltamivir
  9. 1.4 Global Influenza NA Inhibitor Market Size by Type
  10. 1.4.1 Global Influenza NA Inhibitor Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Influenza NA Inhibitor Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Influenza NA Inhibitor Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Influenza NA Inhibitor Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Influenza NA Inhibitor Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Influenza NA Inhibitor Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Influenza NA Inhibitor Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Influenza NA Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Influenza NA Inhibitor Industry Trends
  2. 2.2 Influenza NA Inhibitor Industry Drivers
  3. 2.3 Influenza NA Inhibitor Industry Opportunities and Challenges
  4. 2.4 Influenza NA Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Influenza NA Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by Influenza NA Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by Influenza NA Inhibitor Price (2021-2026)
  4. 3.4 Global Influenza NA Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza NA Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global Influenza NA Inhibitor Company, Product Type & Application
  7. 3.7 Global Influenza NA Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza NA Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza NA Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza NA Inhibitor Tier 1, Tier 2, and Tier 3
4 Influenza NA Inhibitor Regional Status and Outlook
  1. 4.1 Global Influenza NA Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Influenza NA Inhibitor Historic Market Size by Region
  3. 4.2.1 Global Influenza NA Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Influenza NA Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Influenza NA Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Influenza NA Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global Influenza NA Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Influenza NA Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Influenza NA Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Influenza NA Inhibitor by Application
  1. 5.1 Influenza NA Inhibitor Market by Application
  2. 5.1.1 Influenza A Treatment
  3. 5.1.2 Influenza B Treatment
  4. 5.2 Global Influenza NA Inhibitor Market Size by Application
  5. 5.2.1 Global Influenza NA Inhibitor Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Influenza NA Inhibitor Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Influenza NA Inhibitor Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Influenza NA Inhibitor Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Influenza NA Inhibitor Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Influenza NA Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Influenza NA Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Influenza NA Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ATK Chemical
  2. 6.1.1 ATK Chemical Company Information
  3. 6.1.2 ATK Chemical Business Overview
  4. 6.1.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ATK Chemical Influenza NA Inhibitor Product Portfolio
  6. 6.1.5 ATK Chemical Recent Developments
  7. 6.2 Chemwill Asia Co.,Ltd.
  8. 6.2.1 Chemwill Asia Co.,Ltd. Company Information
  9. 6.2.2 Chemwill Asia Co.,Ltd. Business Overview
  10. 6.2.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product Portfolio
  12. 6.2.5 Chemwill Asia Co.,Ltd. Recent Developments
  13. 6.3 Green Cross
  14. 6.3.1 Green Cross Company Information
  15. 6.3.2 Green Cross Business Overview
  16. 6.3.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Green Cross Influenza NA Inhibitor Product Portfolio
  18. 6.3.5 Green Cross Recent Developments
  19. 6.4 Moksha8 Pharma
  20. 6.4.1 Moksha8 Pharma Company Information
  21. 6.4.2 Moksha8 Pharma Business Overview
  22. 6.4.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Moksha8 Pharma Influenza NA Inhibitor Product Portfolio
  24. 6.4.5 Moksha8 Pharma Recent Developments
  25. 6.5 NeoPharm
  26. 6.5.1 NeoPharm Company Information
  27. 6.5.2 NeoPharm Business Overview
  28. 6.5.3 NeoPharm Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NeoPharm Influenza NA Inhibitor Product Portfolio
  30. 6.5.5 NeoPharm Recent Developments
  31. 6.6 Shionogi Co.
  32. 6.6.1 Shionogi Co. Company Information
  33. 6.6.2 Shionogi Co. Business Overview
  34. 6.6.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shionogi Co. Influenza NA Inhibitor Product Portfolio
  36. 6.6.5 Shionogi Co. Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Influenza NA Inhibitor Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Henan DaKen Chemical
  44. 6.8.1 Henan DaKen Chemical Company Information
  45. 6.8.2 Henan DaKen Chemical Business Overview
  46. 6.8.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Henan DaKen Chemical Influenza NA Inhibitor Product Portfolio
  48. 6.8.5 Henan DaKen Chemical Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Influenza NA Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche Influenza NA Inhibitor Product Portfolio
  54. 6.9.5 Roche Recent Developments
7 North America by Country
  1. 7.1 North America Influenza NA Inhibitor Sales by Country
  2. 7.1.1 North America Influenza NA Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Influenza NA Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America Influenza NA Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Influenza NA Inhibitor Market Size by Country
  6. 7.2.1 North America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Influenza NA Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America Influenza NA Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Influenza NA Inhibitor Sales by Country
  2. 8.1.1 Europe Influenza NA Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Influenza NA Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe Influenza NA Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Influenza NA Inhibitor Market Size by Country
  6. 8.2.1 Europe Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Influenza NA Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Influenza NA Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Influenza NA Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific Influenza NA Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Influenza NA Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Influenza NA Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Influenza NA Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Influenza NA Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Influenza NA Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Influenza NA Inhibitor Sales by Country
  2. 10.1.1 South America Influenza NA Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Influenza NA Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America Influenza NA Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Influenza NA Inhibitor Market Size by Country
  6. 10.2.1 South America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Influenza NA Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America Influenza NA Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Influenza NA Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa Influenza NA Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Influenza NA Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Influenza NA Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Influenza NA Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Influenza NA Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Influenza NA Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Influenza NA Inhibitor Value Chain Analysis
  2. 12.1.1 Influenza NA Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Influenza NA Inhibitor Production Mode & Process
  7. 12.2 Influenza NA Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Influenza NA Inhibitor Distributors
  10. 12.2.3 Influenza NA Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst